HSAQ vs. NSPR, CTCX, TMDIF, GBS, RVP, PETV, NURO, BTCY, INVO, and TTOO
Should you be buying Health Sciences Acquisitions Co. 2 stock or one of its competitors? The main competitors of Health Sciences Acquisitions Co. 2 include InspireMD (NSPR), Carmell (CTCX), Titan Medical (TMDIF), GBS (GBS), Retractable Technologies (RVP), PetVivo (PETV), NeuroMetrix (NURO), Biotricity (BTCY), INVO Bioscience (INVO), and T2 Biosystems (TTOO). These companies are all part of the "surgical & medical instruments" industry.
Health Sciences Acquisitions Co. 2 vs. Its Competitors
InspireMD (NYSE:NSPR) and Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, valuation, risk, institutional ownership, dividends, analyst recommendations and media sentiment.
44.8% of InspireMD shares are held by institutional investors. Comparatively, 89.7% of Health Sciences Acquisitions Co. 2 shares are held by institutional investors. 29.7% of InspireMD shares are held by insiders. Comparatively, 21.9% of Health Sciences Acquisitions Co. 2 shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
InspireMD presently has a consensus target price of $4.50, suggesting a potential upside of 99.56%. Given InspireMD's stronger consensus rating and higher possible upside, equities analysts clearly believe InspireMD is more favorable than Health Sciences Acquisitions Co. 2.
Health Sciences Acquisitions Co. 2 has lower revenue, but higher earnings than InspireMD.
Health Sciences Acquisitions Co. 2 has a net margin of 0.00% compared to InspireMD's net margin of -413.96%. Health Sciences Acquisitions Co. 2's return on equity of 0.00% beat InspireMD's return on equity.
In the previous week, InspireMD's average media sentiment score of 0.95 beat Health Sciences Acquisitions Co. 2's score of 0.00 indicating that InspireMD is being referred to more favorably in the media.
InspireMD has a beta of 0.59, meaning that its stock price is 41% less volatile than the S&P 500. Comparatively, Health Sciences Acquisitions Co. 2 has a beta of 0.09, meaning that its stock price is 91% less volatile than the S&P 500.
Summary
InspireMD beats Health Sciences Acquisitions Co. 2 on 7 of the 12 factors compared between the two stocks.
Get Health Sciences Acquisitions Co. 2 News Delivered to You Automatically
Sign up to receive the latest news and ratings for HSAQ and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding HSAQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Health Sciences Acquisitions Co. 2 Competitors List
Related Companies and Tools
This page (NASDAQ:HSAQ) was last updated on 7/3/2025 by MarketBeat.com Staff
